Piper Sandler Upgrades Medtronic to Overweight, Raises Price Target to $120

Benzinga · 4d ago
Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.